Scotland invests further in genomic medicine with up to £3.5 million for industry-led projects.
We are launching the Genomic Medicine Industrial Catalyst Fund, which will invest in using genetic information to guide the diagnosis and treatment of disease.
Who can apply?
The fund is open to Scottish and international life sciences companies, including consortia constituted with academic partners.
Individuals planning to set up a business and SMEs are eligible to apply if they are based in Scotland or planning to establish their business in Scotland within the next two years. You are eligible to apply for funding if you are planning to use or work with Scottish genomic sequencing facilities to develop solutions and products to support genomic medicine.
About the fund
Research and development projects may involve genome sequencing activity or workflow/supply chain solutions. For example, projects may involve: sample management; bioinformatics; software pipelines; computer hardware; and diagnostic development. Applications may include development and deployment of secure, robust data-sharing infrastructure.
Projects must have a defined market-need and be commercially viable.
Including other investments, there will be up to £22 million invested from Scotland in genome sequencing technology.
How to apply
This is an open call and expressions of interest can be submitted at any time. For multi-party projects, each company will need to submit an individual form, along with a multi-party project summary expression of interest form. You will be able to apply for further funding rounds over the next 5 years.
The award panel will include members from the University of Edinburgh, the University of Glasgow and different areas within Scottish Enterprise.
Download an application form (Word doc, 3MB)
If you are thinking of making an application, the Stratified Medicine Scotland-Innovation Centre (SMS-IC) can support you in developing a suitable project. They are based at the Queen Elizabeth University Hospital (QEUH) in Glasgow and provide genetic sequencing (both DNA and RNA modalities) in-house and through their partner organisations. Their partner organisations include Universities in Scotland and NHS in Grampian, Lothian, Tayside and Greater Glasgow and Clyde.
SMS-IC support the development of new and better targeted medicines by pharmaceutical and biotech companies. They partner with pharmaceutical and biotech companies who are aiming to better understand response to therapy or disease progression questions to support their own R&D programmes. They can help you manage your project from an initial idea right through to implementation.
You can find out more at the Stratified Medicine Scotland website.
Visit the website